Bosh sahifa007575 ā¢ KRX
add
Ilyang Pharmaceutical Co Ltd Preference Shares
Yopilish kursi
12Ā 330,00Ā ā©
Kunlik diapazon
12Ā 290,00Ā ā© - 12Ā 350,00Ā ā©
Yillik diapazon
9Ā 470,00Ā ā© - 15Ā 590,00Ā ā©
Bozor kapitalizatsiyasi
241,91Ā mlrd KRW
OŹ»rtacha hajm
1,94Ā ming
Narx/foyda
22,08
Dividend daromadliligi
1,22%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 8,52Ā mlrd | 2Ā 284,02% |
Joriy xarajat | -29,83Ā mlrd | 0,09% |
Sof foyda | 3,69Ā mlrd | 151,01% |
Sof foyda marjasi | 43,34 | 102,14% |
Har bir ulushga tushum | ā | ā |
EBITDA | 1,03Ā mlrd | -63,71% |
Amaldagi soliq stavkasi | 11,98% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 12,79Ā mlrd | -6,57% |
Jami aktivlari | 431,21Ā mlrd | 9,83% |
Jami passivlari | 189,63Ā mlrd | 16,91% |
Umumiy kapital | 241,58Ā mlrd | ā |
Tarqatilgan aksiyalar | 18,01Ā mln | ā |
Narxi/balansdagi bahosi | 0,94 | ā |
Aktivlardan daromad | -0,02% | ā |
Kapitaldan daromad | -0,03% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 3,69Ā mlrd | 151,01% |
Operatsiyalardan naqd pul | 20,22Ā mlrd | 66,89% |
Sarmoyadan naqd pul | -8,96Ā mlrd | -120,91% |
Moliyadan naqd pul | -15,72Ā mlrd | -87,00% |
Naqd pulning sof oŹ»zgarishi | -4,57Ā mlrd | -109,83% |
BoŹ»sh pul | -4,54Ā mlrd | -122,24% |
Haqida
Tashkil etilgan
1946
Xodimlar soni
637
